Tumor homing molecules, conjugates derived therefrom, and methods of using same
AssigneeThe Burnham Institute
InventorsErkki Ruoslahti, Renata Pasqualini
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Burnham Institute
InventorsErkki Ruoslahti, Renata Pasqualini
Estimating the term…
The present invention provides tumor homing molecules, which selectively home to a tumor. The invention also provides methods of using a tumor homing molecule to target an agent such as a drug to a selected tumor or to identify the target molecule expressed by the tumor. The invention also provides methods of targeting a tumor containing angiogenic vasculature by contacting the tumor with a molecule that specifically binds an αv-containing integrin. The invention further provides molecules that can selectively home to angiogenic vasculature. In addition, the invention provides a target molecule, which is specifically bound by a tumor homing molecule and is expressed by angiogenic vasculature. The invention also provides antibodies that bind to the target molecule and peptidomimetics that competitively inhibit binding of a ligand to the target molecule.
A conjugate, comprising a tumor homing peptide linked to a moiety, said tumor homing peptide obtained by in vivo panning, comprising the steps of:
A conjugate, comprising a tumor homing molecule linked to a moiety, said tumor homing molecule obtained by in vivo panning, comprising the steps of:
A conjugate, comprising a tumor homing peptide containing the amino acid sequence RGD, said tumor homing peptide linked to a moiety.
A conjugate, comprising a tumor homing peptide containing the amino acid sequence NGR, said tumor homing peptide linked to a moiety.
A conjugate, comprising a tumor homing peptide containing the amino acid sequence GSL, said tumor homing peptide linked to a moiety.
A conjugate, comprising a tumor homing peptide selected from the group consisting of NGRAHA (SEQ ID NO:
A conjugate, comprising CDCRGDCFC (SEQ ID NO:
A conjugate, comprising a tumor homing peptide selected from the group consisting of CNGRCVSGCAGRC (SEQ ID NO:
A tumor homing peptide identified by in vivo panning, comprising the steps of:
A tumor homing peptide selected from the group consisting of CNGRCVSGCAGRC (SEQ ID NO:
A tumor homing molecule identified by in vivo panning, comprising the steps of:
A method of identifying the presence of a target molecule, which specifically binds a tumor homing molecule, wherein said tumor homing molecule is not an antibody, comprising contacting a sample of a tumor with the tumor homing molecule and detecting specific binding of said tumor homing molecule to a component of said sample, said binding identifying the presence of a target molecule.
A method of identifying a target molecule, which is expressed in a tumor tissue, comprising the steps of:
A target molecule, which is expressed in tumor vasculature, wherein said target molecule binds CNGRC (SEQ ID NO:
A method of targeting in vivo a tumor containing angiogenic vasculature, comprising contacting the tumor with a molecule that selectively binds an αv-containing integrin.
Dependencies are inferred from the claim text.